Allegra Medical Technologies (AMT.AX) Stock Price
Allegra Medical Technologies Price
Revenue at Allegra Medical Technologies has contracted by 45.5% per year over the past 18 years to 100.00 AUD. Earnings per share have declined at 0.5% per year over the last 12 years. Allegra Medical Technologies's net margin stands at -3,647,700.0%, down from -12.9% several years earlier.
Allegra Medical Technologies stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Allegra Medical Technologies business model & stock analysis
Frequently asked questions about Allegra Medical Technologies
The business model of Allegra Orthopaedics Ltd revolves around developing and commercializing innovative orthopedic implants and surgical instruments. With a focus on the extremities market, the company aims to provide solutions for a wide range of orthopedic conditions and injuries. Allegra Orthopaedics leverages its expertise in research and development to design and manufacture high-quality, patient-specific implants that offer improved surgical outcomes. By collaborating with surgeons and healthcare professionals, the company strives to address unmet needs in the orthopedic industry and enhance patient care. Allegra Orthopaedics Ltd is dedicated to delivering innovative orthopedic solutions, contributing to the advancement of orthopedic surgery.
Allegra Orthopaedics Ltd is primarily active in the healthcare industry, specifically specializing in the field of orthopedics.
The main competitors of Allegra Orthopaedics Ltd in the market include established orthopedic companies such as Johnson & Johnson's DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings Inc., and Medtronic plc. These companies also specialize in manufacturing and supplying orthopedic devices and implants.
Allegra Orthopaedics Ltd is an Australian-based company specializing in the design, development, and distribution of innovative orthopedic implant solutions. Established in 2014, Allegra Orthopaedics focuses on developing implants that provide better patient outcomes and improve surgical techniques. The company's commitment to research and development has led to the introduction of innovative products tailored to the needs of surgeons and patients. With a team of experienced professionals and strategic partnerships, Allegra Orthopaedics aims to improve the quality of life for individuals requiring orthopedic interventions.
Allegra Orthopaedics Ltd has achieved several significant milestones since its establishment. The company has successfully developed and launched innovative orthopedic solutions, providing efficient and reliable treatments for various musculoskeletal conditions. Additionally, Allegra Orthopaedics Ltd has gained regulatory approvals and certifications for its products, ensuring their quality and safety. The company has also established strategic partnerships and collaborations with renowned healthcare institutions, enabling it to expand its market reach and enhance its research and development capabilities. Furthermore, Allegra Orthopaedics Ltd has achieved remarkable financial growth and recognition within the orthopedic industry, solidifying its position as a leading provider of orthopedic solutions.
Allegra Orthopaedics Ltd is primarily present in Australia and New Zealand.
Allegra Orthopaedics Ltd represents a strong commitment to providing innovative orthopaedic solutions. The company's corporate philosophy revolves around delivering superior patient outcomes, fostering collaborative partnerships, and embracing technological advancements in orthopaedic care. With a focus on research and development, Allegra Orthopaedics strives to introduce cutting-edge products and surgical techniques that enhance patient mobility and quality of life. As a leader in the orthopaedic industry, Allegra Orthopaedics is dedicated to maintaining the highest standards of integrity, professionalism, and customer satisfaction.
Converted at the current exchange rate, the Allegra Medical Technologies share trades at 0.02 EUR (0.03 AUD).
The Allegra Medical Technologies share (AMT.AX) is listed on 1 stock exchanges, including: ASX (AMT.AX).
The company Allegra Orthopaedics Ltd is a medical company specializing in the development, manufacturing, and distribution of innovative orthopedic implants. Its goal is to improve the quality of life for patients by offering top-notch solutions for orthopedic problems. The company is headquartered in Australia and operates in other countries such as the USA, Europe, and Asia.
The revenue cannot currently be calculated for Allegra Medical Technologies.
The profit cannot currently be calculated for Allegra Medical Technologies.
The P/E ratio cannot be calculated for Allegra Medical Technologies at the moment.
The P/S cannot be calculated for Allegra Medical Technologies currently.
The Eulerpool Quality Score for Allegra Medical Technologies is 4/10.
The ISIN of Allegra Medical Technologies is AU000000AMT8. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Allegra Medical Technologies is A0M7NQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Allegra Medical Technologies is AMT.AX. The ticker symbol is used to trade Allegra Medical Technologies shares on the stock exchange.
Allegra Medical Technologies stock
Allegra Medical Technologies Peer Group
Allegra Medical Technologies Ticker
Allegra Medical Technologies FIGI
All fundamentals and in-depth analysis of Allegra Medical Technologies
Our stock analysis for Allegra Medical Technologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Allegra Medical Technologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.